Simon Barry J.
Insider CIK 1647994 · VIRX Director · IBRX See remarks, Director · CUE Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IBRX ImmunityBio, Inc. | S Sale | 2026-10-05 | 2026-10-06 | 25,000 | $10.75 | $268.8K | 2,777,788 | SEC↗ |
| IBRX ImmunityBio, Inc. | S Sale | 2026-06-24 | 2026-06-26 | 25,000 | $7.88 | $197.0K | 2,802,788 | SEC↗ |
| IBRX ImmunityBio, Inc. | S Sale | 2026-06-04 | 2026-06-05 | 23,033 | $7.18 | $165.4K | 2,827,788 | SEC↗ |
| IBRX ImmunityBio, Inc. | S Sale | 2026-02-24 | 2026-02-26 | 75,000 | $12.01 | $900.8K | 2,850,821 | SEC↗ |
| IBRX ImmunityBio, Inc. | S Sale | 2026-02-23 | 2026-02-24 | 165,000 | $10.25 | $1.69M | 2,925,821 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise deriv | 2026-02-22 | 2026-02-24 | 15,243 | — | $0 | 15,245 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise | 2026-02-22 | 2026-02-24 | 15,243 | — | $0 | 3,096,847 | SEC↗ |
| IBRX ImmunityBio, Inc. | F Tax w/h | 2026-02-22 | 2026-02-24 | 6,026 | $8.70 | $52.4K | 3,090,821 | SEC↗ |
| IBRX ImmunityBio, Inc. | S Sale | 2026-02-20 | 2026-02-24 | 10,000 | $9.25 | $92.5K | 3,081,604 | SEC↗ |
| IBRX ImmunityBio, Inc. | S Sale | 2026-01-20 | 2026-01-21 | 76,967 | $6.54 | $503.4K | 3,166,604 | SEC↗ |
| IBRX ImmunityBio, Inc. | S Sale | 2026-01-20 | 2026-01-21 | 75,000 | $7.88 | $591.0K | 3,091,604 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise deriv | 2025-02-22 | 2025-02-25 | 15,243 | — | $0 | 30,488 | SEC↗ |
| IBRX ImmunityBio, Inc. | F Tax w/h | 2025-02-22 | 2025-02-25 | 5,453 | $3.42 | $18.6K | 3,243,571 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise | 2025-02-22 | 2025-02-25 | 15,243 | — | $0 | 3,249,024 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise deriv | 2025-01-22 | 2025-01-24 | 110,020 | — | $0 | 0 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise | 2025-01-22 | 2025-01-24 | 110,020 | $2.00 | $220.0K | 3,233,781 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | A Award deriv | 2024-06-20 | 2024-06-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| IBRX ImmunityBio, Inc. | A Award deriv | 2024-02-22 | 2024-02-26 | 45,731 | — | $0 | 45,731 | SEC↗ |
| IBRX ImmunityBio, Inc. | A Award deriv | 2024-02-22 | 2024-02-26 | 159,146 | — | $0 | 159,146 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise deriv | 2024-01-31 | 2024-02-02 | 57,200 | — | $0 | 0 | SEC↗ |
| IBRX ImmunityBio, Inc. | F Tax w/h | 2024-01-31 | 2024-02-02 | 22,094 | $3.36 | $74.2K | 3,123,761 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise | 2024-01-31 | 2024-02-02 | 57,200 | — | $0 | 3,145,855 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise deriv | 2023-09-01 | 2023-09-06 | 57,199 | — | $0 | 57,200 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise | 2023-09-01 | 2023-09-06 | 57,199 | — | $0 | 3,088,655 | SEC↗ |
| IBRX ImmunityBio, Inc. | A Award deriv | 2023-08-25 | 2023-08-28 | 114,399 | — | $0 | 114,399 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | A Award deriv | 2023-06-08 | 2023-06-09 | 40,000 | — | $0 | 40,000 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | A Award deriv | 2022-06-09 | 2022-06-10 | 40,000 | — | $0 | 40,000 | SEC↗ |
| IBRX ImmunityBio, Inc. | A Award deriv | 2022-03-23 | 2022-03-25 | 10,714 | — | $0 | 10,714 | SEC↗ |
| IBRX ImmunityBio, Inc. | S Sale | 2021-05-25 | 2021-05-25 | 88,787 | $16.18 | $1.44M | 3,102,507 | SEC↗ |
| IBRX ImmunityBio, Inc. | S Sale | 2021-05-24 | 2021-05-25 | 21,223 | $16.02 | $340.0K | 3,191,294 | SEC↗ |
| IBRX ImmunityBio, Inc. | S Sale | 2021-05-21 | 2021-05-25 | 14,990 | $16.09 | $241.2K | 3,212,517 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise deriv | 2021-05-05 | 2021-05-07 | 56,967 | — | $0 | 0 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise | 2021-05-05 | 2021-05-07 | 56,967 | $1.75 | $99.7K | 3,227,507 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | A Award deriv | 2021-03-26 | 2021-03-30 | 80,000 | — | $0 | 80,000 | SEC↗ |
| NK NantKwest, Inc. | M Exercise deriv | 2021-02-05 | 2021-02-08 | 22,100 | — | $0 | 110,020 | SEC↗ |
| NK NantKwest, Inc. | S Sale | 2021-02-05 | 2021-02-08 | 22,100 | $23.09 | $510.3K | 3,170,540 | SEC↗ |
| NK NantKwest, Inc. | M Exercise | 2021-02-05 | 2021-02-08 | 22,100 | $2.00 | $44.2K | 3,192,640 | SEC↗ |
| NK NantKwest, Inc. | M Exercise deriv | 2021-02-02 | 2021-02-04 | 82,070 | — | $0 | 132,120 | SEC↗ |
| NK NantKwest, Inc. | M Exercise | 2021-02-02 | 2021-02-04 | 82,070 | $2.00 | $164.1K | 3,252,610 | SEC↗ |
| NK NantKwest, Inc. | S Sale | 2021-02-02 | 2021-02-04 | 82,070 | $20.65 | $1.69M | 3,170,540 | SEC↗ |
| NK NantKwest, Inc. | M Exercise deriv | 2021-01-28 | 2021-01-29 | 11,304 | — | $0 | 214,190 | SEC↗ |
| NK NantKwest, Inc. | S Sale | 2021-01-28 | 2021-01-29 | 11,304 | $20.53 | $232.1K | 3,170,540 | SEC↗ |
| NK NantKwest, Inc. | M Exercise | 2021-01-28 | 2021-01-29 | 11,304 | $2.00 | $22.6K | 3,181,844 | SEC↗ |
| NK NantKwest, Inc. | M Exercise deriv | 2021-01-27 | 2021-01-29 | 36,626 | — | $0 | 225,494 | SEC↗ |
| NK NantKwest, Inc. | S Sale | 2021-01-27 | 2021-01-29 | 36,626 | $20.61 | $754.9K | 3,170,540 | SEC↗ |
| NK NantKwest, Inc. | M Exercise | 2021-01-27 | 2021-01-29 | 36,626 | $2.00 | $73.3K | 3,207,166 | SEC↗ |
| CUE Cue Biopharma, Inc. | A Award deriv | 2021-01-04 | 2021-01-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| NK NantKwest, Inc. | M Exercise deriv | 2020-12-22 | 2020-12-28 | 130,000 | — | $0 | 262,120 | SEC↗ |
| NK NantKwest, Inc. | S Sale | 2020-12-22 | 2020-12-28 | 130,000 | $18.05 | $2.35M | 3,170,540 | SEC↗ |
| NK NantKwest, Inc. | M Exercise | 2020-12-22 | 2020-12-28 | 130,000 | $2.00 | $260.0K | 3,300,540 | SEC↗ |
| NK NantKwest, Inc. | M Exercise deriv | 2020-07-21 | 2020-07-22 | 1,565 | — | $0 | 392,120 | SEC↗ |
| NK NantKwest, Inc. | S Sale | 2020-07-21 | 2020-07-22 | 1,565 | $15.50 | $24.3K | 3,170,540 | SEC↗ |
| NK NantKwest, Inc. | M Exercise | 2020-07-21 | 2020-07-22 | 1,565 | $2.00 | $3.1K | 3,172,105 | SEC↗ |
| NK NantKwest, Inc. | M Exercise deriv | 2020-07-20 | 2020-07-22 | 87,705 | — | $0 | 393,685 | SEC↗ |
| NK NantKwest, Inc. | M Exercise deriv | 2020-07-20 | 2020-07-22 | 40,730 | — | $0 | 56,967 | SEC↗ |
| NK NantKwest, Inc. | M Exercise | 2020-07-20 | 2020-07-22 | 87,705 | $2.00 | $175.4K | 3,298,975 | SEC↗ |
| NK NantKwest, Inc. | M Exercise | 2020-07-20 | 2020-07-22 | 40,730 | $1.76 | $71.7K | 3,211,270 | SEC↗ |
| NK NantKwest, Inc. | S Sale | 2020-07-20 | 2020-07-22 | 128,435 | $15.53 | $1.99M | 3,170,540 | SEC↗ |
| NK NantKwest, Inc. | M Exercise deriv | 2020-07-08 | 2020-07-10 | 39,950 | — | $0 | 97,697 | SEC↗ |
| NK NantKwest, Inc. | S Sale | 2020-07-08 | 2020-07-10 | 39,950 | $13.14 | $524.9K | 3,170,540 | SEC↗ |
| NK NantKwest, Inc. | M Exercise | 2020-07-08 | 2020-07-10 | 39,950 | $1.76 | $70.3K | 3,210,490 | SEC↗ |
| NK NantKwest, Inc. | M Exercise deriv | 2020-06-30 | 2020-07-02 | 9 | — | $0 | 137,647 | SEC↗ |
| NK NantKwest, Inc. | S Sale | 2020-06-30 | 2020-07-02 | 9 | $13.00 | $117 | 3,170,540 | SEC↗ |
| NK NantKwest, Inc. | M Exercise | 2020-06-30 | 2020-07-02 | 9 | $1.76 | $16 | 3,170,549 | SEC↗ |
| NK NantKwest, Inc. | M Exercise deriv | 2020-06-23 | 2020-06-23 | 29,609 | — | $0 | 137,656 | SEC↗ |
| NK NantKwest, Inc. | M Exercise | 2020-06-23 | 2020-06-23 | 29,609 | $1.76 | $52.1K | 3,200,149 | SEC↗ |
| NK NantKwest, Inc. | S Sale | 2020-06-23 | 2020-06-23 | 29,609 | $13.01 | $385.2K | 3,170,540 | SEC↗ |
| NK NantKwest, Inc. | M Exercise deriv | 2020-06-22 | 2020-06-23 | 136,729 | — | $0 | 167,265 | SEC↗ |
| NK NantKwest, Inc. | S Sale | 2020-06-22 | 2020-06-23 | 66,263 | $9.43 | $624.9K | 3,260,972 | SEC↗ |
| NK NantKwest, Inc. | S Sale | 2020-06-22 | 2020-06-23 | 10,432 | $13.01 | $135.7K | 3,170,540 | SEC↗ |
| NK NantKwest, Inc. | S Sale | 2020-06-22 | 2020-06-23 | 80,000 | $10.55 | $844.0K | 3,180,972 | SEC↗ |
| NK NantKwest, Inc. | M Exercise | 2020-06-22 | 2020-06-23 | 136,729 | $1.76 | $240.6K | 3,327,235 | SEC↗ |
| NK NantKwest, Inc. | M Exercise deriv | 2020-06-19 | 2020-06-23 | 9,337 | — | $0 | 303,994 | SEC↗ |
| NK NantKwest, Inc. | S Sale | 2020-06-19 | 2020-06-23 | 13,737 | $9.00 | $123.6K | 3,190,506 | SEC↗ |
| NK NantKwest, Inc. | M Exercise | 2020-06-19 | 2020-06-23 | 9,337 | $1.76 | $16.4K | 3,204,243 | SEC↗ |
| NK NantKwest, Inc. | S Sale | 2020-05-27 | 2020-05-29 | 75,000 | $7.56 | $567.0K | 3,194,906 | SEC↗ |
| NK NantKwest, Inc. | S Sale | 2020-05-21 | 2020-05-22 | 36,932 | $5.52 | $203.9K | 3,269,906 | SEC↗ |
| NK NantKwest, Inc. | S Sale | 2020-05-11 | 2020-05-13 | 28,068 | $5.50 | $154.4K | 3,306,838 | SEC↗ |
| CUE Cue Biopharma, Inc. | A Award deriv | 2020-01-02 | 2020-01-06 | 9,600 | — | $0 | 9,600 | SEC↗ |
| CUE Cue Biopharma, Inc. | A Award deriv | 2019-01-02 | 2019-01-03 | 9,600 | — | $0 | 9,600 | SEC↗ |
| NK NantKwest, Inc. | A Award deriv | 2018-08-27 | 2018-08-29 | 200,000 | — | $0 | 200,000 | SEC↗ |
| CUE Cue Biopharma, Inc. | M Exercise deriv | 2018-06-12 | 2018-06-14 | 8,000 | — | $0 | 8,000 | SEC↗ |
| NK NantKwest, Inc. | S Sale | 2016-09-08 | 2016-09-09 | 30,000 | $7.40 | $222.0K | 3,334,906 | SEC↗ |
| NK NantKwest, Inc. | S Sale | 2016-09-07 | 2016-09-09 | 2,000 | $8.84 | $17.7K | 21,143 | SEC↗ |
| NK NantKwest, Inc. | M Exercise deriv | 2016-07-27 | 2016-07-28 | 185,150 | — | $0 | 0 | SEC↗ |
| NK NantKwest, Inc. | F Tax w/h | 2016-07-27 | 2016-07-28 | 79,322 | $6.89 | $546.5K | 3,364,906 | SEC↗ |
| NK NantKwest, Inc. | M Exercise | 2016-07-27 | 2016-07-28 | 185,150 | — | $0 | 3,444,228 | SEC↗ |
| NK NantKwest, Inc. | M Exercise deriv | 2015-07-27 | 2015-08-05 | 185,150 | — | $0 | 185,150 | SEC↗ |
| NK NantKwest, Inc. | A Award deriv | 2015-07-27 | 2015-08-05 | 370,300 | — | $0 | 370,300 | SEC↗ |
| NK NantKwest, Inc. | A Award deriv | 2015-07-27 | 2015-08-05 | 555,450 | — | $0 | 555,450 | SEC↗ |
| NK NantKwest, Inc. | M Exercise | 2015-07-27 | 2015-08-05 | 185,150 | — | $0 | 3,355,690 | SEC↗ |
| NK NantKwest, Inc. | F Tax w/h | 2015-07-27 | 2015-08-05 | 96,612 | $25.00 | $2.42M | 3,259,078 | SEC↗ |